The Role of Continuing Perioperative Chemotherapy Post Surgery in Patients with Esophageal or Gastroesophageal Junction Adenocarcinoma: a Multicenter Cohort Study

George Papaxoinis,Konstantinos Kamposioras,Jamie M. J. Weaver,Zoe Kordatou,Sofia Stamatopoulou,Theodora Germetaki,Magdy Nasralla,Vikki Owen-Holt,Alan Anthoney,Wasat Mansoor

The Role of Continuing Perioperative Chemotherapy Post Surgery in Patients with Esophageal or Gastroesophageal Junction Adenocarcinoma: a Multicenter Cohort Study

2019

George Papaxoinis
Konstantinos Kamposioras
Jamie M. J. Weaver
Zoe Kordatou
Sofia Stamatopoulou
Theodora Germetaki
Magdy Nasralla
Vikki Owen-Holt
Alan Anthoney
Wasat Mansoor

Purpose The aim of this cohort study was to assess the benefit that patients with lower esophageal or gastroesophageal junction (E/GEJ) adenocarcinoma receive by continuing perioperative chemotherapy post-surgery.

Keywords:

Gastroesophageal Junction Adenocarcinoma
Cohort study
Surgery
Gastroesophageal Junction
Medicine
Adenocarcinoma
Chemotherapy
Perioperative
Capecitabine
Hazard ratio
Propensity score matching
Epirubicin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations